Authors: Marra, F Robbins, GM Masri, BA Duncan, C Wasan, KM Kwong, EH Jewesson, PJ

Citation: F. Marra et al., Amphotericin B-loaded bone cement to treat osteomyelitis caused by Candidaalbicans, CAN J SURG, 44(5), 2001, pp. 383-386

Authors: Wai, AO Frighetto, L Marra, CA Chan, E Jewesson, PJ

Citation: Ao. Wai et al., Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme - A Canadian teaching hospital and ministry of health perspective, PHARMACOECO, 18(5), 2000, pp. 451-457

Authors: Frighetto, L Marra, CA Stiver, HG Bryce, EA Jewesson, PJ

Citation: L. Frighetto et al., Economic impact of standardized orders for antimicrobial prophylaxis program, ANN PHARMAC, 34(2), 2000, pp. 154-160

Authors: Marra, CA Frighetto, L Quaia, CB de Lemos, ML Warkentin, DI Marra, F Jewesson, PJ

Citation: Ca. Marra et al., A new ciprofloxacin stepdown program in the treatment of high-risk febrileneutropenia: A clinical and economic analysis, PHARMACOTHE, 20(8), 2000, pp. 933-942

Authors: Zed, PJ Stiver, HG Devonshire, V Jewesson, PJ Marra, F

Citation: Pj. Zed et al., Continuous intrathecal pump infusion of baclofen with antibiotic drugs fortreatment of pump-associated meningitis - Case report, J NEUROSURG, 92(2), 2000, pp. 347-349

Authors: Marra, FO Frighetto, LO Marra, CA Sleigh, KM Stiver, HG Bryce, EA Reynolds, RP Jewesson, PJ

Citation: Fo. Marra et al., Cost-minimization analysis of piperacillin/tazobactam versus imipenem/cilastatin for the treatment of serious infections: A Canadian hospital perspective, ANN PHARMAC, 33(2), 1999, pp. 156-162